In-stent restenosis of drug-eluting stents

被引:10
作者
Minha, Sa'ar [1 ,2 ]
Pichard, Augusto D. [1 ,2 ]
Waksman, Ron [1 ,2 ]
机构
[1] MedStar Washington Hosp Ctr, Intervent Cardiol, Washington, DC USA
[2] MedStar Washington Hosp Ctr, Washington, DC 20010 USA
关键词
bare metal stent; drug-eluting stent; in-stent restenosis;
D O I
10.2217/FCA.13.45
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic dilemma. Recent insights regarding the pathophysiological processes and therapeutic alternatives have added to the accumulated knowledge regarding the appropriate approach to this phenomenon. This review aims to detail the mechanism and clinical presentation of, and therapeutic strategies for, the treatment of DES in in-stent restenosis.
引用
收藏
页码:721 / 731
页数:11
相关论文
共 63 条
  • [1] Sirolimus-Eluting Stent Versus Balloon Angioplasty for Sirolimus-Eluting Stent Restenosis: Insights From the j-Cypher Registry
    Abe, Mitsuru
    Kimura, Takeshi
    Morimoto, Takeshi
    Taniguchi, Takuya
    Yamanaka, Futoshi
    Nakao, Kazuhiro
    Yagi, Nobuhito
    Kokubu, Nobuaki
    Kasahara, Yoichiro
    Kataoka, Yu
    Otsuka, Yoritaka
    Kawamura, Atsushi
    Miyazaki, Shunichi
    Nakao, Koichi
    Horiuchi, Kenji
    Ito, Akira
    Hoshizaki, Hiroshi
    Kawaguchi, Ren
    Setoguchi, Manabu
    Inada, Tsukasa
    Kishi, Koichi
    Sakamoto, Hiroki
    Morioka, Nobuyuki
    Imai, Masao
    Shiomi, Hiroki
    Nonogi, Hiroshi
    Mitsudo, Kazuaki
    [J]. CIRCULATION, 2010, 122 (01) : 42 - U89
  • [2] Implantation of a Drug-Eluting Stent With a Different Drug (Switch Strategy) in Patients With Drug-Eluting Stent Restenosis Results From a Prospective Multicenter Study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent])
    Alfonso, Fernando
    Perez-Vizcayno, Maria J.
    Dutary, Jaime
    Zueco, Javier
    Cequier, Angel
    Garcia-Touchard, Arturo
    Marti, Vicens
    Lozano, Inigo
    Angel, Juan
    Hernandez, Jose M.
    Lopez-Minguez, Jose R.
    Melgares, Rafael
    Moreno, Raul
    Seidelberger, Bernhard
    Fernandez, Cristina
    Hernandez, Rosana
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (07) : 728 - 737
  • [3] Strut position, blood flow, and drug deposition - Implications for single and overlapping drug-eluting stents
    Balakrishnan, B
    Tzafriri, AR
    Seifert, P
    Groothuis, A
    Rogers, C
    Edelman, ER
    [J]. CIRCULATION, 2005, 111 (22) : 2958 - 2965
  • [4] Bonaventura K, 2011, EUROINTERVENTION, V7, pK106, DOI 10.4244/EIJV7SKA18
  • [5] Vascular Brachytherapy for Patients with Drug-Eluting Stent Restenosis
    Bonello, Laurent
    Kaneshige, Kimberly
    De Labriolle, Axel
    Roy, Probal
    Lemesle, Gilles
    Torguson, Rebecca
    Satler, Lowell F.
    Pichard, Augusto D.
    Lindsay, Joseph
    Waksman, Ron
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2008, 21 (06) : 528 - 534
  • [6] Byrne RA, 2012, TRANSC CARD THER 201
  • [7] Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer
    Byrne, Robert A.
    Iijima, Raisuke
    Mehilli, Julinda
    Pinieck, Susanne
    Bruskina, Olga
    Schoemig, Albert
    Kastrati, Adnan
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (04) : 291 - 299
  • [8] Predictive Factors of Re-restenosis after Repeated Sirolimus-Eluting Stent Implantation for SES Restenosis and Clinical Outcomes after Percutaneous Coronary Intervention for SES Restenosis
    Chatani, Kenichi
    Muramatsu, Toshiya
    Tsukahara, Reiko
    Ito, Yoshiaki
    Ishimori, Hiroshi
    Hirano, Keisuke
    Nakano, Masatsugu
    Yamawaki, Masahiro
    Araki, Motoharu
    Sakurai, Masayuki
    Iuchi, Kazuyuki
    Nozawa, Takashi
    Inoue, Hiroshi
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2009, 22 (04) : 354 - 361
  • [9] Bare metal stent restenosis is not a benign clinical entity
    Chen, Michael S.
    John, Jim M.
    Chew, Derek P.
    Lee, David S.
    Ellis, Stephen G.
    Bhatt, Deepak L.
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (06) : 1260 - 1264
  • [10] One-Year Results of the CRISTAL Trial, a Randomized Comparison of Cypher Sirolimus-Eluting Coronary Stents versus Balloon Angioplasty for Restenosis of Drug-Eluting Stents
    Chevalier, Bernard
    Moulichon, Robert
    Teiger, Emmanuel
    Brunel, Philippe
    Metzger, Jean-Philippe
    Pansieri, Michel
    Carrie, Didier
    Stoll, Hans-Peter
    Wittebols, Kristel
    Spaulding, Christian
    Fajadet, Jean
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2012, 25 (06) : 586 - 595